Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRHa Plus Letrozole in Obese Progestin-insensitive EAH
NCT06390904Phase 3Active, not recruiting
- Start
- Jul 2022
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole in Atypical endometrial hyperplasia (AEH). Started Jul 2022; status: active, not recruiting.
02
Drugs
letrozole
03
Conditions
Atypical endometrial hyperplasia (AEH)
Beyond the preview
Go deeper on NCT06390904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06390904.